Pine Pharmaceuticals, LLC 2022-09-21 Health serious FDA
Health · FDA · Recall #FDA-D-1514-2022
Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or… Recall
Issued September 21, 2022 · Pine Pharmaceuticals, LLC
In September 2022, Pine Pharmaceuticals, LLC recalled the Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Pine Pharmaceuticals, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Pine Pharmaceuticals, LLC
- Category
- Health
- Recall date
- September 21, 2022
- Units affected
- Not reported
- Sold at
- Product was distributed to direct accounts in AL, CA, NC and NY
- Recall number
- FDA-D-1514-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Pine Pharmaceuticals, LLC has 8 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.